pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 371 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health131
viewlistcards
  • Phase 3
    freneslerbart + mevonlerbart
    freneslerbart + mevonlerbart
    Cat Allergy$REGN REGENERON PHARMACEUTICALS, INC.
  • Marketed
    garadacimab
    Andembry (garadacimab [INN])
    Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-IN… CSL Behring LLC
  • pre_registration
    gefurulimab
    gefurulimab
    Myasthenia Gravis Alexion Pharmaceuticals Inc
← prev
page 10 of 13
next →
Pain89
Neurology1
Marketed
golimumab
Simponi (golimumab)
Ankylosing Spondylitis (Bekhterev's Disease)
Janssen Biotech Inc
  • pre_registration
    golimumab biosimilar
    Ankylosing Spondylitis (Bekhterev's Disease) Bio-Thera Solutions Ltd
  • Marketed
    grass pollen [cocksfoot (Dactylis glomerata) + sweet vernal (Anthoxanthum odoratum) + rye (Lolium perenne) + meadow (Poa pratensis) + timothy (Phleum pratense)] allergen extract
    Oralair
    Grass Pollen Allergy Greer Laboratories Inc
  • Marketed
    halcinonide
    Halcinonide
    Atopic Dermatitis (Atopic Eczema) Encube Ethicals Inc
  • Marketed
    halobetasol propionate
    Halobetasol Propionate
    Psoriasis G&W Laboratories Inc
  • Marketed
    hydrocortisone butyrate
    Locoid (hydrocortisone butyrate)
    Atopic Dermatitis (Atopic Eczema) Bausch Health Americas Inc
  • Marketed
    hydrocortisone valerate
    Hydrocortisone Valerate
    Atopic Dermatitis (Atopic Eczema) Cosette Pharmaceuticals Inc
  • Marketed
    hydroxychloroquine
    Hydroxychloroquine Sulfate (hydroxychloroquine [INN])
    Malaria Creekwood Pharmaceutical Inc
  • Marketed
    hymenoptera venom allergen extract
    White Faced Hornet Hymenoptera Venom Multidose
    Allergies Jubilant HollisterStier LLC
  • Phase 3
    hypericin sodium
    hypericin sodium
    Cutaneous T-Cell Lymphoma$SNGX SOLIGENIX, INC.
  • Phase 3
    ianalumab
    ianalumab
    Idiopathic Thrombocytopenic Purpura (Immune Thrombocytope…$NVS NOVARTIS AG
  • Marketed
    ibrutinib
    Imbruvica (ibrutinib)
    Follicular Lymphoma$ABBV AbbVie Inc.
  • Marketed
    icatibant acetate
    Firazyr (icatibant acetate)
    Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-IN… Takeda Pharmaceuticals USA Inc
  • Phase 2
    ifetroban
    Dyscorban (ifetroban)
    Duchenne Muscular Dystrophy$CPIX CUMBERLAND PHARMACEUTICALS INC
  • Phase 2
    ignaseclant
    ignaseclant
    Myasthenia Gravis NMD Pharma AS
  • Phase 3
    imeroprubart
    imeroprubart
    Rheumatoid Arthritis$IMVT Immunovant, Inc.
  • pre_registration
    imlifidase
    Idefirix (imlifidase)
    Kidney Transplant Rejection Hansa Biopharma AB
  • pre_registration
    imsidolimab
    imsidolimab
    Generalized Pustular Psoriasis (GPP)$VNDA Vanda Pharmaceuticals Inc.
  • Marketed
    indomethacin sodium
    Indomethacin Sodium
    Patent Ductus Arteriosus Hikma Pharmaceuticals USA Inc
  • Marketed
    inebilizumab
    Uplizna (inebilizumab)
    Immunoglobulin G4-Related Disease (IgG4-RD) Horizon Therapeutics USA Inc
  • Marketed
    infliximab
    Remicade (infliximab)
    Plaque Psoriasis (Psoriasis Vulgaris) Janssen Biotech Inc
  • Marketed
    iptacopan hydrochloride
    Fabhalta (iptacopan hydrochloride)
    Myasthenia Gravis$NVS NOVARTIS AG
  • Marketed
    ixekizumab
    Taltz (ixekizumab)
    Plaque Psoriasis (Psoriasis Vulgaris) Eli Lilly and Co
  • Marketed
    lanadelumab
    Takhzyro (lanadelumab-flyo)
    Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-IN… Takeda Pharmaceuticals USA Inc
  • Marketed
    leniolisib
    Joenja (leniolisib [INN])
    Common Variable Immunodeficiency (CVID) Pharming Group NV
  • Marketed
    levofloxacin
    Levofloxacin
    Acute Bacterial Sinusitis Teva Pharmaceuticals USA Inc
  • Phase 3
    litifilimab
    litifilimab
    Cutaneous Lupus Erythematosus$BIIB BIOGEN INC.